Sanofi’s dengue vaccine Dengvaxia’s checkered growth trajectory may be under further strain, with an expert group of the World Health Organization recommending a “pre-vaccination screening strategy” as the “preferred option” in countries evaluating vaccination as part of their dengue control program.
Only dengue-seropositive persons should be vaccinated under this plan, the Strategic Advisory Group of Experts (SAGE) on Immunization, the principal...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
